Digging into new ethical issues around stem cells

May 22, 2018, Johns Hopkins University School of Medicine

Discussions concerning to the ethical issues related to stem cells have been ongoing for many years, but a special section in the latest issue of Perspectives in Biology and Medicine takes a deep look at some of the newest and most complex issues—including the direct global sales of services and untested and unproven products marketed as stem cells.

Guest edited by Tamra Lysaght and Jeremy Sugarman, the special section on Ethics, Policy, and Autologous Cellular Therapies in Volume 61, Issue 1 includes six essays that examine the potential impacts of using a person's own stem cells on patients, health-care systems and the public trust in science and .

"Many scholars in bioethics, law, medicine, philosophy, sociology and stem cell science worry such practices will place patients at risk of unnecessary harm and exploit vulnerable populations with unsubstantiated claims of clinical benefit," says Lysaght, Assistant Professor in the Centre for Biomedical Ethics at the National University of Singapore.

The issue developed from a symposium held in Singapore in May 2017. The symposium was a collaboration between the Centre for Biomedical Ethics at the National University of Singapore, the Johns Hopkins Berman Institute of Bioethics, the Sydney Law School and the Stem Cell Society, Singapore.

The issue will be available for free on Project MUSE for a limited time. The journal is published by the Johns Hopkins University Press.

"Many of the bioethical and regulatory issues related to autologous stem remain under examined. We planned the symposium to help fill the gap in research and are proud to release a series of peer-reviewed papers that resulted in Perspectives in Biology and Medicine, says Sugarman, the Harvey M. Meyerhoff Professor of Bioethics and Medicine, at the Johns Hopkins Berman Institute of Bioethics.

Following an introductory essay written by Lysaght and Sugarman, the issue features the work of Leigh Turner ("The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions"), Douglas Sipp ("Challenges in the Regulation of Autologous Stem Cell Interventions in the United States"), Christopher Hauskeller ("Between the Local and the Global: Evaluating European Regulation of Stem Cell Regenerative Medicine"), Tsung-Ling Lee and Tamra Lysaght ("Conditional Approvals for Autologous Stem Cell-Based Interventions: Conflicting Norms and Institutional Legitimacy"), Tereza Hendl ("Vulnerabilities and the Use of Autologous Stem Cells for Medical Conditions in Australia,") and Wendy Lipworth, Cameron Stewart and Ian Kerridge ("The Need for Beneficence and Prudence in Clinical Innovation with Autologous Stem Cells").

"This group of papers shows the importance of a journal like Perspectives," says editor Martha Montello, Lecturer on Global Health and Social Medicine at Harvard Medical School. "We're proud of our ability to further public policy debates about challenging ethical issues and regulatory concerns through outstanding peer-reviewed papers like these."

Explore further: Treating myasthenia gravis with autologous hematopoietic stem cell transplants

Related Stories

Treating myasthenia gravis with autologous hematopoietic stem cell transplants

April 4, 2016
A report on seven cases of severe myasthenia gravis (an autoimmune disease characterized by severe muscle weakness) suggests that autologous hematopoietic stem cell transplantation (when a patient's own stem cells are used) ...

Stem cell clinics and businesses are registering for-profit, pay-to-participate

July 19, 2017
The Future Science Group (FSG) journal Regenerative Medicine, today announces the publication of a new Perspective article, in which Leigh Turner (University of Minnesota, MN, USA) discusses the urgent need for careful screening ...

Of mice and men: Stem cells and ethical uncertainties

October 29, 2009
The recent creation of live mice from induced pluripotent stem cells (iPSCs) not only represents a remarkable scientific achievement, but also raises important issues, according to bioethicists at The Johns Hopkins University's ...

Ethicists explore civil lawsuits as a tool to push for regulation of unproven, direct-to-consumer stem cell therapies

February 20, 2018
In the realm of direct-to-consumer marketing for unproven therapies, a staggeringly large number of stem cell interventions have emerged in the United States. A new report from Baylor College of Medicine and Mayo Clinic demonstrates ...

Structure of a stem cell niche

March 1, 2018
Stem cells—specialized cells that can self-renew and generate functional cells—maintain adult tissues. They reside in a specialized microenvironment, known as a niche, that regulates their self-renewal and activities. ...

Stem cell transplant may be effective for systemic sclerosis

February 7, 2018
(HealthDay)—Stem cell transplant may be an effective treatment for systemic sclerosis (SSc), according to a small study published online Feb. 2 in the International Journal of Rheumatic Diseases.

Recommended for you

Tongue-in-cheek Nobels honor nutritional analysis of cannibalism, roller-coaster kidney stones treatment

September 14, 2018
A nutritional analysis of cannibalism and treating kidney stones on roller-coasters were research projects honored by tongue-in-cheek awards at Harvard University Thursday, designed to make you laugh first, and think later.

Pediatric robot patient offers new level of realism for doctors in training

September 10, 2018
A team of researchers and engineers at Gaumard Scientific has unveiled a new robot that raises the bar on medical training devices. The robot, called HAL, has been made to look like a five-year-old male patient and offers ...

Why men say they've had more lifetime sexual partners than women

July 25, 2018
The disparity between the number of sexual partners reported by men and women can largely be explained by a tendency among men to report extreme numbers of partners, and to estimate rather than count their lifetime total, ...

Censors jump into action as China's latest vaccine scandal ignites

July 22, 2018
Chinese censors on Sunday deleted articles and postings about the vaccine industry as an online outcry over the country's latest vaccine scandal intensified.

Revenge of a forgotten medical 'genius'

June 30, 2018
It's not an uncommon fate for a pioneering scientist: languishing unrecognised in his time before dying in obscurity. But as his 200th birthday approaches, the life-saving work of a Hungarian obstetrician is finally getting ...

Yes, you can put too much chlorine in a pool

June 2, 2018
(HealthDay)—Before you take a dip in the pool this summer, be sure there's not too much chlorine in the water.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.